Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer

The purpose of this study was to investigate whether tumor‐infiltrating immune cells in biopsy specimens can be used to predict the clinical outcome of stage IV nonsmall cell lung cancer (NSCLC) patients.

[1]  Ö. Özdemir.  Can a mast cell subtype (MCT) play a role in the progression of endometrial cancer through angiogenesis , 2006 .

[2]  C. Liu,et al.  Targeting tumor-associated macrophages as a novel strategy against breast cancer. , 2006, The Journal of clinical investigation.

[3]  Teruhiko Yoshida,et al.  Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: clinical implications. , 2006, International journal of oncology.

[4]  Y. Song,et al.  Transfection of mouse macrophage metalloelastase gene into murine CT-26 colon cancer cells suppresses orthotopic tumor growth, angiogenesis and vascular endothelial growth factor expression. , 2006, Cancer letters.

[5]  T. Oshikiri,et al.  Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma , 2006, British Journal of Cancer.

[6]  K. O'Byrne,et al.  Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Crivellato,et al.  Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. , 2005, American journal of obstetrics and gynecology.

[8]  M. Smyth,et al.  Supernatural T cells: genetic modification of T cells for cancer therapy , 2005, Nature Reviews Immunology.

[9]  S. Tsutsui,et al.  Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. , 2005, Oncology reports.

[10]  Yi-Chen Lin,et al.  Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Fisker,et al.  Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma , 2004, Cancer Immunology, Immunotherapy.

[12]  T. Oshikiri,et al.  CD8+ Tumor-Infiltrating Lymphocytes Together with CD4+ Tumor-Infiltrating Lymphocytes and Dendritic Cells Improve the Prognosis of Patients with Pancreatic Adenocarcinoma , 2004, Pancreas.

[13]  T. Oshikiri,et al.  Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response , 2003, Journal of surgical oncology.

[14]  G. Soma,et al.  The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. , 2003, Anticancer research.

[15]  T. Oshikiri,et al.  Clinical significance of immune cell infiltration within gallbladder cancer , 2003, British Journal of Cancer.

[16]  T. Oshikiri,et al.  CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. , 2003, Cancer research.

[17]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[18]  N. Martinet,et al.  Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. , 2002, The Journal of laboratory and clinical medicine.

[19]  P. Bunn.  Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[21]  David Harrington,et al.  Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. , 2002, The New England journal of medicine.

[22]  L. Hakansson,et al.  Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes , 2001, British Journal of Cancer.

[23]  Y. Kimura,et al.  [Angiogenesis and macrophage infiltration in Borrmann type IV gastric cancer]. , 2001, Fukuoka igaku zasshi = Hukuoka acta medica.

[24]  J. Crowley,et al.  Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  P. Schlag,et al.  Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. , 2001, Cancer research.

[26]  A. Hongo,et al.  Macrophage infiltration and angiogenesis in endometrial cancer. , 2000, Anticancer research.

[27]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  K. Kelly,et al.  New combinations in the treatment of lung cancer: a time for optimism. , 2000, Chest.

[29]  A. Harris,et al.  Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer , 2000, The Journal of pathology.

[30]  P. Quaglino,et al.  Macrophage‐mediated immunostimulation modulates therapeutic efficacy of interleukin‐2 based chemoimmunotherapy in advanced metastatic melanoma patients , 2000, Melanoma research.

[31]  Y. Matsuzaki,et al.  Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. , 1999, Lung cancer.

[32]  J. Okamura,et al.  Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis , 1999, Gastric Cancer.

[33]  H Nagura,et al.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. , 1998, Cancer research.

[34]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[35]  V. Kosma,et al.  Mast cells in breast cancer. , 1993, Anticancer research.

[36]  Takeo Takahashi,et al.  Roles of langerhans' cells and T‐lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer , 1992, Cancer.

[37]  H. Rockette,et al.  Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). , 1989, Human pathology.

[38]  G. Scapigliati,et al.  In vitro generated mast cells express natural cytotoxicity against tumour cells. , 1985, Immunology.

[39]  E. Chi,et al.  Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system , 1981, The Journal of experimental medicine.

[40]  D. Nelson,et al.  Mouse mast cells as anti-tumor effector cells. , 1980, Cellular immunology.

[41]  O. Ozdemir.  Can a mast cell subtype (MC(T)) play a role in the progression of endometrial cancer through angiogenesis? , 2006, American journal of obstetrics and gynecology.

[42]  J. M. Masa Jiménez,et al.  [Overall long-term survival in lung cancer analyzed in 610 unselected patients]. , 2004, Archivos de bronconeumologia.

[43]  J. Miranda,et al.  Supervivencia global a largo plazo en el cáncer de pulmón. Análisis de una serie de 610 pacientes no seleccionados , 2004 .

[44]  S. Toda,et al.  Mast cells and angiogenesis , 2003, Microscopy research and technique.